SEC Form 4 · accession 0001225208-15-012204
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Huimin Wang
Officer — CVP, Japan & Intercontinental
Period of report
May 13, 2015
Accepted (ET)
May 15, 2015 · 6:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 13, 2015 | M | 1,026 | $0.00 | A | 32,906 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Performance RightsF1 | — | May 13, 2015 | D | 134 | D | — | Mar 31, 2015 | Common Stock | 134 | 2,091 | D |
| Performance RightsF1 | — | May 13, 2015 | M | 1,026 | D | — | Mar 31, 2015 | Common Stock | 1,026 | 1,065 | D |
| Performance RightsF1,F2 | — | May 13, 2015 | F | 1,065 | D | — | Mar 31, 2015 | Common Stock | 1,065 | 0 | D |
Explanation of responses
- F1On May 9, 2012, the reporting person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 13, 2015, 94% of the target shares vested and were issued and the balance of the award terminated.
- F2This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.